论文部分内容阅读
The individualized care of glioma patients ought to benefit from imaging biomarkers as precocious predictors of therapeutic efficacy.Contrast enhanced MRI and[(18)F]-fluorodeoxyglucose(FDG)-PET are routinely used in clinical settings;their ability to forecast the therapeutic response is controversial.The objectives of our preclinical study were to analyze sensitiveμMRI and/orμPET imaging biomarkers to predict the efficacy of
The individualized care of glioma patients ought to benefit from imaging biomarkers as precocious predictors of therapeutic efficacy. Contrast enhanced MRI and [(18) F] -fluorodeoxyglucose (FDG) -PET are routinely used in clinical settings; their ability to forecast the therapeutic response is controversial.The objectives of our preclinical study were to analyze sensitive μMRI and / or μPET imaging biomarkers to predict the efficacy of